Clinical trial
High Dose CHOP in Lymphoma
NCT00192764 · Rambam Health Care Campus, Other · Completed
Key facts
| NCT number | NCT00192764 |
|---|---|
| Title | High Dose CHOP in Lymphoma |
| Official title | Phase II Study of Short High-dose CHOP Chemotherapy for Aggressive Non-Hodgkin's Lymphoma |
| Lead sponsor | Rambam Health Care Campus, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | high-dose cyclophosphamide |
| Enrollment | 45 |
| Start date | Dec 1, 1996 |
| Completion | Sep 1, 2010 |
| First posted | Sep 19, 2005 |
| Last update posted | Sep 22, 2010 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: